The Parkinson's Network

Stem cell treatment of Parkinson's disease

Parkinson's disease

 

Parkinson's disease is a movement disorder and it is characterised by muscle rigidity, tremor and a slowing of physical movement. This is caused by the degenerative character of the disease, which primarily affects the central nervous system and leads to an impairment of motor and speech skills and a number of other body functions.

 

The Xcell-Center Parkinson's disease treatment

 

The stem cells are first collected from a patient’s bone marrow, extracted from the hipbone (iliac crest) then implanted back into the body days later. Prior to re-implantation of the cells, the bone marrow is processed in one of our labs, where the quantity and quality of the stem cells is also checked.

 

These re-injected stem cells have the potential to transform into multiple types of cells and are capable of regenerating damaged tissue. Our innovative stem cell treatments use the self-healing potential of each patient’s own body to stimulate regeneration or repair.

 

Results

 

In the bar graph below you can see the results (up to May 2008) of a survey of 11 of our Parkinson's disease patients. The survey was conducted one

to six months after the treatment of each patient.

• One patient reported no change in muscle spasticity, sensation, mobility or feeling of well-being after the treatment.

• Two out of 11 patients reported an overall improvement, with improved mobility (legs, arms) and/or improved strength. Some patients reported a regaining of muscle strength and/or an improvement of balance. There was some improvement of speech and/or a reduction of pain and spasms.

• Eight out of 11 patients reported a strong improvement, with a marked improvement of mobility, speech and significantly reduced pain and spasms.

• No patients reported a perceived deterioration of the quality of their life.